BioCryst names David Jenkins as chief scientific officer

Go back to BioCryst names David Jenkins as chief scientific officer
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.70 --0 (-0%)
Previous Close $8.70    52 Week High $10.98 
Open $8.70    52 Week Low $1.63 
Day High $8.70    P/E N/A 
Day Low $8.70    EPS $-0.68 
Volume 230